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Abstract
Experiments were performed to quantitatively characterize the differential
migratory response of human keratinocytes to the polypeptide growth factors
EGF and TGF-a. Videomicroscopic tracking of single cells, on collagen IV
surfaces, was used to examine the migratory response of cells to a range of
growth factor concentrations, as well as to the EGF receptor blocking antibody
225. Results indicate that both EGF and TGF-0a increase the random motility
coefficient of human keratinocytes, relative to control experiments and those
in which EGFR blocking antibody is used. This increase in motility appears to
occur in a dose-dependent manner, with TGF-a performing as a stronger
motogen than EGF. Results also suggest that the addition of exogenous
growth factor or receptor blocking antibody lowers cellular persistence times
relative to the control state. This finding supports a model of autocrine
pathways as cellular environmental sensing systems, a model that has been
termed "cell sonar".
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Chapter 1
Introduction and Background
1.1 The Epidermal Growth Factor Receptor and its Cognate
Family of Ligands
The epidermal growth factor receptor (EGFR) is arguably the most thoroughly
characterized member of the receptor tyrosine kinase family of signaling
molecules. This 175 kDa, single chain, transmembrane glycoprotein is
composed of 1186 amino acids and N-linked carbohydrates (Pimentel, 1994).
As shown in Figure 1, the receptor has a 621 amino acid extracellular ligand
binding domain, a 22 amino acid transmembrane region, and a 542 amino
acid intracellular domain. Furthermore, the intracellular region is comprised
of both a tyrosine kinase and a regulatory domain (Chang et al., 1993). All of
the several intracellular signaling cascades that can be activated by the EGFR,
upon binding of a cognate ligand, depend in part on the successful
dimerization of receptors and autophosphorylation of intracellular tyrosine
residues. Subsequent to autophosphorylation events, SH2 domains on other
intracellular proteins involved in signaling pathways, such as PLC-y, GAP,
SHC, and GRB-2, interact with these phosphotyrosine moieties. It is the
interaction of SH2 domains with any of the five intracellular tyrosine
residues of the EGFR that allows the receptor to participate in many
important signaling pathways (reviewed by van der Geer et al., 1994).
The physiological importance of the EGFR is highlighted by its presence on
numerous cell types (Carpenter and Wahl, 1990; Gospodarowicz, 1981) and
the variety of responses it is capable of eliciting. The actual outcome of
receptor activation is a function of tissue location and state of differentiation
of the host cell (Khazaie et al., 1993), however the EGFR has been shown to
participate in the stimulation of cell proliferation, gene induction,
differentiation, and migration (Barrandon and Green, 1987; Carpenter and
Wahl, 1990; Hudson and Gill, 1991; Wells, 1988). In addition to its role in
normal physiology and development, the EGFR is also involved in the
dysregulation of cell function. EGFR expression and activity are associated
with several pre-malignant and malignant pathologies including benign
hyperplasia of the skin, mammary carcinoma, glioblastoma, and hepatic
carcinoma (Khazaie et al., 1993). Indeed, the EGFR is the receptor most
commonly implicated in the pathology of all human cancers (Aaronson,
1991).
Each member of the epidermal growth factor (EGF) family of ligands, which
also includes amphiregulin, betacellulin, heparin-binding EGF (HB-EGF), and
transforming growth factor-alpha (TGF-a), is capable of independently
binding to and activating the EGFR (Soler and Carpenter, 1994). The two
most thoroughly characterized members of this family are EGF and TGF-a.
Both molecules are initially synthesized as transmembrane precursors (Soler
and Carpenter, 1994), and they share a 42% amino acid sequence homology, a
major consequence of which is similar binding affinities to the EGFR
(Burgess, 1989; Lee et al., 1995; Massague, 1983). The dissociation constant (KD)
for both receptor/ligand interactions has been experimentally determined to
be approximately 2 nM (Ebner and Derynck, 1991). Although information
regarding the processing pathway of the precursor EGF molecule is limited,
the mature form, a 6 kDa, 53 amino acid, single polypeptide chain, is known
to originate from a transmembrane precursor that may be as large as 128 kDa
(Carpenter and Cohen, 1990; Gray et al., 1983; Massague and Pandiella, 1993).
TGF-a is synthesized as a 160 amino acid precursor (Bringman et al., 1987), but
some cells cleave this precursor molecule to form several membrane
associated, as well as soluble species, including the mature form, a 6 kDa, 50
amino acid soluble polypeptide (Massague, 1990). In contrast to the
transmembrane precursor of EGF, for which there is no indication of
biological activity (Burgess, 1989), both the precursor and mature form of
TGF-a are able to bind to and activate the EGFR (Brachmann et al., 1989;
Wong et al., 1989).
EGF and TGF-a are known to stimulate a variety of cell types, including
almost all fibroblasts, epithelia, and muscle cells (Burgess, 1989), and both
ligands have been shown to stimulate cell migration (Bade and Nitzgen, 1985;
Barrandon and Green, 1987; Cha et al., 1996), proliferation (Barrandon and
Green, 1987), wound healing (Schultz et al., 1987), neurite extension (Manske
and Bade, 1994), and angiogenesis (Schreiber et al., 1986). Physiologically, EGF
is known only to be released by cells in the salivary gland (Ebner and Derynck,
1991), whereas TGF-a is known to be produced in macrophages (Madtes et al.,
1988; Rappolee et al., 1988), the brain (Wilcox and Derynck, 1988), the pituitary
(Kobrin et al., 1988), and many types of epithelia (Beauchamp et al., 1989;
Coffey et al., 1987; Valverius et al., 1989). Under normal conditions, epithelial
cells are the major source of TGF-a synthesis (Derynck, 1992). Because these
cells also express the EGFR on their surface (Carpenter and Wahl, 1990),
overproduction of TGF-c is directly related to many neoplasias and
hyperproliferative disorders, particularly in human keratinocytes (Bates et al.,
1988; Derynck et al., 1987; Dominey et al., 1993; Nister et al., 1988).
1.2 Cell Migration
Cell migration is an important process that occurs in many aspects of normal
physiology and development, as well as pathology. Examples include the
formation of nervous system structures, a result of the outward migration of
neurons from the neural crest, the movement of neutrophils scavenging
antigenic material, bone remodeling, and the metastasis of tumor cells. More
familiar evidence of this phenomenon is seen in the wound healing process,
during which a progression of immune cells, fibroblasts, and epithelial cells
interact so as to renew the structure of damaged tissue (reviewed by Clark,
1993). Keratinocytes play a pivotal role during the reepithelialization stage of
the wound healing process, moving on the order of hours after injury to close
the wound surface and restore the skin's barrier function (Winter, 1962).
These cells express the EGFR on their surface, as well as produce both TGF-a
and HB-EGF (Derynck, 1992; Hashimoto et al., 1994; Pittelkow et al., 1993).
This autocrine pathway makes examining the migratory response of
keratinocytes to EGFR ligand a more complex issue.
1.3 The Differential Cellular Response Elicited by Epidermal
Growth Factor and Transforming Growth Factor-Alpha
In spite of their similarities, EGF and TGF-a are capable of evoking
differential cellular responses (Barrandon and Green, 1987; Cha et al., 1996;
Ebner and Derynck, 1991; Reddy et al., 1996b; Schreiber et al., 1986).
Specifically, in assays measuring the stimulatory effect of the two ligands on
keratinocyte migration, as well as the ability to modulate in vitro wound
closure, TGF-a displayed stronger motogenic properties than EGF (Cha et al.,
1996). A possible explanation for this effect, one that does not necessitate
differential signaling, is the difference in isoelectric points of the two
molecules (Ebner and Derynck, 1991). This biochemical difference manifests
itself as a variation in the pH sensitivity of the binding affinities of the two
ligands for the EGFR (Ebner and Derynck, 1991; French et al., 1995). At a lower
pH, such as that found in the intracellular vesicles in which the internalized
growth factor-receptor complex is located, the KD for the TGF-a /EGFR
interaction increases approximately twice as much as that of EGF/EGFR
interaction (French et al., 1995). This variation in binding affinity has
significant implications for the intracellular processing pathways of both
ligand and receptor (Reddy et al., 1996b). As a result of the higher
intracellular KD,, relative to EGF, TGF-ca dissociates from the EGFR to a much
greater extent than EGF. Therefore, in accordance with an understanding of
the mechanisms of endosomal sorting (French and Lauffenburger, 1996), the
uncoupled TGF-c ligand is degraded to a greater extent than EGF.
Additionally, a greater fraction of receptors recycles to the cell surface when
internalized with the TGF-ca molecule than when internalized via an
EGF/EGFR complex (Ebner and Derynck, 1991; Reddy et al., 1996b). A critical
examination of EGF and TGF-ax trafficking dynamics in fibroblasts has
demonstrated that the proliferative response to stimulation by these ligands
is not straight forward. In fact, three regimes of behavior (discussed in
chapter 4) were seen (Reddy et al., 1996b). Whether mechanisms governing
cell migration are controlled in the same manner is unclear.
1.4 Thesis Overview
This work brings a rigorously quantitative approach to the analysis of human
keratinocyte migration, for the purpose of elucidating differential effects that
EGF and TGF-a exert on cell migratory behavior. The stimulatory effects of a
range of concentrations of exogenously applied EGF and TGF-a were
examined, as well as the inhibitory effect of EGFR blocking antibody.
Experimental data indicate that both ligands increase the random motility
coefficient of human keratinocytes, relative to control experiments and those
in which EGFR blocking antibody is used. This increase in motility appears to
occur in a dose-dependent manner, with TGF-a performing as a stronger
motogen than EGF. This result is in agreement with predictions one would
make concerning the performance of these ligands, based upon a
consideration of their trafficking properties. Persistence time data reveal
another interesting feature of the cells. Consistent with a model of autocrine
secretion as a method of cell sonar, results suggest that disruption of native
autocrine loops through the addition of exogenous growth factor or receptor
blocking antibody lowers persistence times relative to the control state in
which no perturbations in autocrine loops are introduced.
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Figure 1 The EGF receptor (from Chang et al., 1993). Asterisks indicate
sites of tyrosine phosphorylation.
Chapter 2
Materials and Methods
2.1 Cell Culture
Normal human epidermal keratinocytes, derived from neonatal foreskins
and cultured under serum-free conditions in standard formulation
keratinocyte serum-free medium (KSFM, Gibco BRL, Grand Island, NY), were
a generous gift from Dr. Laurie Hudson (Northwestern University). Cells
were maintained in 25 cm2 tissue culture flasks. For routine maintenance of
keratinocytes, media was supplemented with EGF and bovine pituitary extract
(supplied by the vendor along with the KSFM), as well as 0.1% w/v bovine
serum albumin (BSA), 100 units/mL penicillin, and 100 gg/mL streptomycin
antibiotics. Media for experiments involving the addition of growth factors
consisted of KSFM, 0.1% w/v BSA, antibiotics, and the appropriate amount of
human recombinant EGF or TGF-(o (Gibco BRL, Grand Island, NY). A starve
media, composed only of KSFM and 0.1% w/v BSA, was prepared for the
maintenance of cells 24 hours prior to the start migration experiments.
In passaging and seeding cells, a mixture of 0.25% trypsin and 1 mM EDTA
(Gibco BRL, Grand Island, NY) was used. Upon detachment, ion-free PBS
(Sigma, St. Louis, MO) was added, and the mixture was centrifuged for
approximately 3 minutes at 800-1000 rpm. After centrifugation, the
supernatant was discarded, and the cells were resuspended in routine media.
Cells were then passaged or counted in a hemocytometer in preparation for
seeding. In the latter case, cell viability was assessed using trypan blue stain.
Only cells of passage 9 and lower were used in experiments.
2.2 Migration Assay Protocols
Experiments were conducted in 35 mm tissue culture dishes coated with
collagen IV (Biocoat Plates, Becton Dickonson/Collaborative Biomedical,
Bedford, MA), a large, network forming protein which is the primary
constituent of basement membranes (Yaoita et al., 1978). For all experiments,
approximately 2500 cells were seeded and allowed to attach overnight in
routine media. This low cell density minimized the possibility of cell/cell
interactions throughout the course of experiments. Following the initial
attachment period, cells were given starve media for 24 hours. At the start of
control experiments, dishes were replenished with 4 mL of starve media. At
the start of experiments involving the addition of growth factors, dishes were
replenished with 4 mL of the appropriate growth factor-containing media.
For experiments involving the use of the monoclonal antibody 225 (mAb
225), a 20 nM concentration of antibody in starve media was added to cells.
225 is a clone that specifically binds to the EGFR, inhibiting the binding of
cognate ligands (Kawamoto et al., 1983; Sato et al., 1983). Its KD for the EGFR
has been reported as 0.6-1.3 nM (Sato et al., 1987). For these experiments, cells
were incubated in a 20 nM concentration of antibody in starve media for 24
hours, followed by replenishment with 4 mL of the antibody-containing
media at the start of the tracking experiment.
2.3 Migration Assay Specifications
Motility assays were based on the method of single cell tracking (DiMilla et al.,
1992). After starving cells for 24 hours and replenishing with the appropriate
media, petri dishes were placed into the insert of a motorized stage on a Zeiss
Axiovert 100 inverted microscope (stage and insert from LUDL electronics,
Hawthorne, NY). Cells were viewed using a 10X objective with phase
contrast optics. Physiological conditions were maintained on the stage in two
ways. To maintain temperature, warm water was circulated around the dish,
through ports on the stage insert. To maintain pH and humidity, a
humidified air/CO2 mixture was perfused over the dish, through an
additional port on the stage insert. To expedite the acquisition of data from a
single experiment, a stage controller (nuLogic Inc., Needham, MA) and
appropriate software (Labview, National Instruments, Bloomfield, CT) were
used to control the timing and positioning of the motorized stage. Up to 25
fields were selected at random for each experiment, and each of these user
designated positions was then visited for approximately 30 seconds, every 15
minutes, for the duration of the experiment. Experiments were run for as
long as 24 hours, but no shorter than 10 hours. Approximately 40 cells were
followed per experiment. Time-lapse images of each experiment were
recorded at 1/480th of real time using a Hitachi KP-M1 CCD camera and
Panasonic AG-6720A time-lapse VCR (RPI, Wayland, MA). Only images
taken at least 30 minutes after the addition of growth factor-containing media
were used for analysis.
2.4 Data Analysis and Acquisition
Cell centroids as a function of time were acquired from video recordings of
cell tracking experiments. Tapes were played back on a Panasonic AG-1980
VCR with built-in time-base corrector (Crimson Tech, Cambridge, MA),
through a Power Macintosh 8500 with a Scion VG-5 frame grabber card (Scion
Corp., Frederick, MD). Using image analysis software (NIH Image), pixel
coordinates of individual cell centroids were acquired from the video images
by manually forwarding the tape and selecting cells of interest with the
mouse. Individual fields were followed over time by forwarding the tape at
appropriate intervals, a process that was hastened by the presence of a
time/date stamp recorded on the images from all experiments. Pixel
coordinates were stored in a data file to be used for further analysis.
To analyze cell paths thus acquired, several data manipulations were
required. Due to an offset in stage positioning, stage drift was seen in many of
the experiments. This phenomenon, which can be seen in cell tracks that
appear as straight, parallel lines, was corrected for in the data analysis. Using
cells that exhibited stage drift as their only motion, a drift rate was calculated
in both the x and y direction. The individual cell drift rates were then
averaged over all cells exhibiting this behavior to determine an average drift
rate in both directions. Using average drift rate information, the stage drift
was subtracted from the (x,y) positions of all cells for a given experiment. The
transformation is represented mathematically in eqns (2.1-2.4),
Sx X xend start) eqn (2.1)n/i1
T, =j end Ystart eqn (2.2)
corrected = Xuncorrected -x dt eqn (2.3)
0
Ycorrected = Yuncorrected -T .fdt eqn (2.4)
0
where Y, and T, represent the average drift rates in the x and y direction,
x•varr, Ystar,, xend, and Yend are the pixel coordinates of a given cell at the
beginning and end of an experiment, d represents the total time course of the
experiment, n is the number of cells in the experiment exhibiting this
behavior, and t is the incremental time course of an experiment.
To quantitate cell motility in the most rigorous sense, the migrating cell is
modeled as an isolated particle exhibiting a persistent, random walk in a
uniform environment. Over short time periods, the cell moves in linear
paths, and over longer time periods, the cell path appears completely random
in nature. The time periods described are relative to the persistence time,
which is described as the time period between significant changes in direction
of cell movement. According to this model, the average squared
displacement, d2(t) of a migrating cell, for a period of time t, depends on two
parameters: the cell speed, S, and persistence time, P. The relationship is
described mathematically in eqn (2.5) (Dunn, 1983; Othmer et al., 1988).
d2 (t) = 2S2P[t- P(1- e-'P)] eqn (2.5)
To obtain values for the parameters S and P which characterize the cell's
movement, it is necessary to calculate the average squared displacement as a
function of time for individual cell paths. These values are calculated using
data that describe the (x,y) position of the cell centroid over the time course of
the experiment.
Before calculating the average squared displacement of the cells however, the
data was examined for induction effects that might be present due to the
administration of growth factor after a 24 hour period of starvation. To assess
whether this effect was present, squared displacements for subsequent 15
minute time intervals, d•,(t), were calculated for every cell for the duration of
each experiment. The values at each time point were then averaged over all
cells for which they were computed. The calculations were performed
according to eqns (2.6) and eqn (2.7),
d;(t) = {[x((i + 1)A) - x(iA)] 2 + [y((i + - y(i)]2(1.25)2 eqn (2.6)
d15(t)=  d5(t)i eqn (2.7)
n i=t
where x and y are the pixel coordinates of the cell centroid, A is the 15 minute
time interval between successive acquisition of images of each field, 1.25
gm/pixel is a conversion factor obtained using a stage micrometer and the
image analysis software, n is the total number of cells tracked for a given
experiment, and d,5(t) is the average 15 minute squared displacement as a
function of time for the entire cell population. Additionally, the number of
cells observed throughout the course of the experiment was examined. In the
final data analysis used to calculate speed and persistence, (x,y) data beyond
the time at which the cell population had decreased by more than four cells
was discarded. This ensured that a constant population of randomly selected
cells was used in the calculation of average squared displacements as a
function of time, thus preventing calculations at later times from being biased
towards a population of slower moving cells.
Using the transformed data, average squared displacements as a function of
time, d2 (t), were calculated for each cell using a method of non-overlapping
intervals (Dickinson and Tranquillo, 1993). Calculations were performed
according to eqns (2.8-2.10).
d2 () -' (X(+1)A_ XjA) +(Y(j+I)A jA)2(1.25)2 eqn (2.8)
t j=0
where
n,= ma (i = 1 - E) (largest integer value) eqn (2.9)iA
and
E= mA eqn (2.10)
rmax is the total length of the experiment, Q is the total number of 15 minute
time intervals in the experiment, and n, is the number of intervals of given
time length in the experiment. n, and the corresponding d2 (t) were
calculated for each time point by incrementing the index, i, from 1 to Q, in
integer values, and calculating the appropriate d2 (t). Finally, after calculating
the average squared displacement as a function of time for each cell in the
population, an average squared displacement versus time, d2 (t), was
calculated for the entire population, by averaging the values of the individual
cells. This is represented mathematically in eqn (2.11).
d2 (t) = d2(t)i  eqn (2.11)
n i=1
In obtaining parameter values, a weighted, nonlinear curve fitting routine
was employed. The reciprocal of the standard deviation of the population
average squared displacement, d2 (t), was used for weighting at each time
point. The loss function minimized in performing the curve fit is described
by eqn (2.12),
Loss = (OBS - PRED)2Loss =eqn (2.12)
where PRED is the value of the population average squared displacements as
predicted by eqn (2.5), OBS is the experimental value of the population
average squared displacements as calculated from the data, and s is the
standard deviation of the population average squared displacement at each
time point. Weight factors were used to account for non-uniformly
distributed residuals in the curve fit, a result of the method of non-
overlapping intervals used to calculate such values (Dickinson and
Tranquillo, 1993). Error in parameter estimates was determined by fitting the
95% confidence limits on the population average squared displacements to
eqn (2.5). The parameter values obtained from these curve fits, along with
the parameters characterizing the average squared displacement curve, were
used to calculate a standard error of means for both speed and persistence
time.
Chapter 3
Results
3.1 Cell Tracking Data
In preparation for the calculation of average squared displacements as a
function of time, cell centroid position data was transformed in several ways.
Figure 3.1 shows typical cell tracks obtained from the initial analysis of video
images. Stage drift, present in many of the experiments, was removed from
the data by applying the transformation described in eqns (2.1-2.4). Typical
drift-corrected cell paths are shown in Figure 3.2. In this figure, also called a
wind-rose display (Goodman et al., 1989), cell paths are assigned a starting
coordinate of (0,0). If a chemotactic gradient, or some other gradient to which
cells would respond, were present during the experiments, this type of display
would help to identify the preferred direction of motion. As required by the
persistent random walk model, the cell paths observed appear to be randomly
oriented. Results of calculations designed to look for growth factor induction
effects are shown in Figure 3.3. While no initial time course of activation is
seen, later times indicate a decrease in average squared 15 minute
displacements. As shown in Figure 3.4, by the concomitant decrease in cell
number observed over time (for the experiment described in Figure 3.3), the
decrease in average squared 15 minute displacements was most likely due to
the selection of a slower moving population of cells at later times. Faster
moving cells tend to migrate out from the field of view earlier in
experiments than do the slower moving ones, resulting in the undesirable
occurrence of a non random population of cells at longer times.
3.2 Average Squared Displacements As a Function of Time
After correcting centroid position data for stage drift and discarding data
collected beyond a time in which more than four cells migrated out of the
field of view, average squared displacements as a function of time were
calculated according to eqns (2.8-2.11). Results of these calculations are shown
in Figures 3.5-3.10. In these figures the data points shown represent
population average squared displacements, and the lines represent fits of the
model to the data. Experiments in which a 10 nM concentration of either
growth factor was added to cells show the largest average squared
displacements, while those in which mAb 225 was added to cells appear to
exhibit the lowest displacements. In calculating average squared
displacements, no distinction was made between motile and immotile cells;
all cells were used in the analysis.
3.3 Parameter Estimates of Speed, Persistence, and Random
Motility Coefficient
To estimate speed and persistence time parameters, nonlinear, weighted
curve fits were performed on population average squared displacment data.
Speed and persistence time values resulting from this procedure are shown
in Figures 3.11 and 3.12. Error bars represent the standard error of means. It is
difficult to recognize any trends in speed and persistence time results,
although all concentrations of both growth factors increase cell speed relative
to the control case and that in which receptor blocking antibody was used.
Also, persistence times for experiments involving the addition of growth
factors or receptor blocking antibody are lower than those seen in the control
situation.
Another informative measure of cell motility is the random motility
coefficient. The mathematical relationship among the random motility
coefficient, speed, and persistence time is given in eqn (3.1) (Alt, 1980;
Lauffenburger, 1983).
S= S 2 P (eqn 3.1)2
This parameter is analogous to a molecular diffusion coefficient and is useful
in predicting the time-dependent displacement of a migrating cell. It
represents the interaction of both speed and persistence time. Figures 3.13a-c
show values of random motility coefficients as calculated for each
experimental condition. These figures demonstrate, as expected from
observations of curves representing population average squared displacement
as a function of time (Figures 3.5-3.10), that random motility coefficients are
largest for the case in which 10 nM concentrations of growth factor were
added to cells and lowest when cells were incubated with mAb 225. Figures
13a and 13b indicate that cells respond to both growth factors in a dose-
dependent manner, with mAb 225 serving as an inhibitor of migration.
Figure 13c demonstrates that over the range of growth factor concentrations
studied TGF-a is superior to EGF as a motogenic stimulant. However, data
from experiments in which 1 nM concentrations of TGF-a were used lend a
degree of uncertainty to this assertion.
Figure 3.1 Cell paths as initially acquired from video images. The two
straight, parallel tracks represent the effects of stage drift.
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Figure 3.2 Drift-corrected cell paths.
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Figure 3.4 Number of cells observed over time.
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Figure 3.5 Comparison of average squared displacement of cells
observed under control conditions to those which have been incubated
with EGFR blocking antibody 225.
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Figure 3.6 Comparison of average squared displacement of cells to
which 0.1 nM TGF-0a or EGF has been added.
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Figure 3.7 Comparison of average squared displacement of cells to
which 1 nM TGF-ou or EGF has been added.
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Figure 3.8 Comparison of average squared displacement of cells to
which 10 nM TGF-oc or EGF has been added.
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Figure 3.9 Comparison of average squared displacement of cells to
which 0.1, 1, and 10 nM TGF-oa have been added.
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Chapter 4
Discussion
Both EGF and TGF-oc are strong mitogenic and motogenic factors for human
keratinocytes. The clinical promise of both growth factors in wound healing
situations has been demonstrated (Brown et al., 1989; Schultz et al., 1987), but
so far the creation of effective therapies that rely upon the activity of these, or
other polypeptide growth factors, has been disappointing (reviewed by Meyer-
Ingold, 1993). In designing an effective therapy around the complex
interactions of growth factors and their receptors, a quantitative and
predictable model of performance is desirable. The approach used in this
study is designed to meet such needs.
Results indicate that both ligands significantly increase cell speed relative to
control experiments and those in which EGFR blocking antibody was used.
The unusually high levels of basal migration that occurred in the latter two
cases are most likely a result of the stimulatory substrate used and the
autocrine nature of the cells. Collagen IV, a protein which has been shown to
be a particularly good stimulus for keratinocyte migration (Kim et al., 1994),
was used throughout the study to provide a physiological surface upon which
to observe the movement of these cells. It is thought that integrin adhesion
receptors on the surface of keratinocytes, molecules that are intimately
involved in the cellular adhesion process, may also play a significant role in
transducing migratory signals (Kim et al., 1994), yielding a significant level of
signaling even under control conditions. Perhaps a more conclusive spread
of results could be attained by using a lower concentration of the protein for
migration experiments. Furthermore, keratinocytes constituitively
manufacture and secrete TGF-a and HB-EGF. Secretion rates have not been
characterized for these cells, but it is likely that even in the presence of
receptor blocking antibody, a degree of autocrine capture of ligand occurs,
generating additional migratory signals for the cells.
Motility coefficients appear to exhibit a dose-dependent response to both
growth factors, with TGF-c serving as a stronger motogen than EGF.
However, data from experiments in which 1 nM TGF-a was used as a
stimulant lend a degree of uncertainty to this assertion. In measuring the
ability of growth factors to modulate the net displacement of a cell, the
random motility coefficient is most likely the variable of interest. As
discussed previously (section 3.3), this parameter represents the interaction of
both speed and persistence time. When considered individually, neither
speed nor persistence time can be used to accurately predict net displacements,
as a cell that moves with a high speed and low persistence will have the same
net displacement, after a given period of time, as a cell that moves more
slowly but with greater persistence.
The autocrine nature of these cells brings an additional level of interest and
complexity to the analysis of their migration. A complete understanding of
the mechanisms of autocrine regulation is lacking, and a major advantage of
the type of analysis performed is that it allows for rigorous testing of theories
regarding the functional role of autocrine pathways as well as other migratory
mechanisms.
In particular, the persistence time contains information about how a cell
responds to its environment. Previous investigations of cell sensing
mechanisms have focused mainly on the perception of chemotactic gradients
(DeLisi et al., 1982; Tranquillo and Lauffenburger, 1986; Tranquillo and
Lauffenburger, 1987; Tranquillo et al., 1988), however the persistence time is a
useful measure of how a cell responds to any environmental cue.
Mathematically, it is also related to parameters that describe the signaling
characteristics of a cell, such as the signal response and decay time constants
(Tranquillo and Lauffenburger, 1987). Unlike the case of the random motility
coefficient, no trend is apparent in persistence time data. However, while not
quite statistically significant (p>0.05), the data suggest that persistence times
for all experiments in which either exogenous growth factor or receptor
blocking antibody was added to cells are lower than those seen in the control
situation. This observation has significant implications concerning the
functional role of autocrine ligands.
Autocrine ligands are initially secreted by and subsequently bind to receptors
on the same cell. As shown in Figure 4.1, in between secretion and binding
steps, interaction of ligand with the cellular microenvironment allows the
molecule to receive information. This information is transmitted back to the
cell upon binding of the autocrine ligand. It has been proposed that the
manner in which an autocrine cell secretes ligand, which then transmits
environmental information back to the cell, is analogous to the emission of
radio waves by sonar devices. As such, this secretion pathway and its
corresponding function have been described as "cell sonar" (personal
communication, H.S. Wiley & D.A. Lauffenburger).
In the case of a migrating autocrine cell, shown in Figure 4.2, the persistent
movement of the cell is assumed to be due to the symmetrical, polarized
secretion and binding of an autocrine factor. Experiments designed to
confirm this assumption would be particularly informative, as this model
predicts that any agent perturbing the homeostasis of these autocrine loops,
such as exogenous ligand or receptor blocking antibody, would diminish the
persistence of the migrating, autocrine cell. Analogous to the "cell sonar"
description, the cell would be essentially "blinded" by such agents. This
situation is depicted in Figure 4.3. Indeed, this prediction corresponds to
results obtained from this investigation. Control cells, in which autocrine
loops remain unpertubed, show a higher persistence time than cells to which
exogenous growth factor or receptor blocking antibody has been added.
Previous studies have highlighted the greater motogenic responsiveness of
keratinocytes to TGF-a than EGF. In one study, cells were plated in the center
of culture vessels, and the increase in radial size of colonies was observed to
be greater in the presence of TGF-a than in the presence of EGF (Barrandon
and Green, 1987). In another study, growth factor effects were screened using
phagokinetic and wound healing assays, which also showed TGF-a to be a
stonger motogenic agent than EGF (Cha et al., 1996). While these approaches
suggest trends in the responsiveness of keratinocytes to EGF and TGF-a, they
are not fundamentally quantitative in nature. Another investigation of the
differential effects of EGF and TGF-a, on the stimulation of fibroblast
proliferation, indicated that a range of responses could be elicited by these
ligands (Reddy et al., 1996a; Reddy et al., 1996b). Focusing on receptor/ligand
trafficking dynamics, three regimes of action were shown. One in which EGF
performed as a stronger mitogen, one in which TGF-ca performed as a
stronger mitogen, and one in which the two ligands were shown to be
equipotent. The same study showed that the response could be predicted by a
knowledge of whether the system was limited by the amount of available
ligand, receptor downregulation, or neither. In comparing these results to the
experiments performed in the present study, ELISAs have shown that ligand
availability was not a determinant of the response, as no growth factor
depletion was observed. Receptor levels were not quantified.
To examine trafficking dynamics further, a mathematical model describing
the binding/trafficking properties of an autocrine cell was developed. Major
assumptions were made concerning the trafficking properties of both EGF and
TGF-a. Namely, all internalized EGF complexes were assumed to be
completely degraded, and all receptors having entered the cell via a TGF-
a/receptor complex were assumed to be completely recycled. Such polarized
assumptions were made to accentuate the main difference between the two
ligands- their intracelluar KD. Model equations, nomenclature, and
parameter values chosen are shown in Appendices A and B. Equations were
solved at steady state, and ligand concentrations were assumed to be constant.
Example results of this type of analysis are shown in Figure 4.4. As expected,
results of this analysis indicate that over a range of ligand concentrations,
exogenously added TGF-a always forms a larger number of growth
factor/receptor complexes at steady state than exogenously added EGF.
Assuming that the degree of migration signaling is proportional to the
number of growth factor/receptor complexes, this result also predicts TGF-c
to be a stronger motogen, over all ligand concentrations. The random
motility coefficients obtained from this study confirm this behavior.
Other approaches explaining the differential effects of EGF and TGF-a have
focused on the possibility of differential signaling pathways of receptor
tyrosine kinases. In support of this theory, a limited number of differences in
Western blots, prepared to examine the magnitude and kinetics of tyrosine
phosphorylation as induced by EGF and TGF-a, suggested different signaling
activities of the two ligands (Cha et al., 1996). Another study demonstrated a
correlation between growth factor specificity and matrix metalloproteinase
activity, as assayed by gelatin zymography (McCawley et al., 1996). These
results are encouraging, but not quantiatively conclusive. The in vivo
cellular response most likely involves a combination of differential
trafficking and signaling pathways, however additional study will be
necessary to fully appreciate the complexity of such interactions.
Microenvironment
Detection
Figure 4.1 An autocrine cell sensing its local microenvironment
(adapted from H.S. Wiley).
Direction of
Motion
Figure 4.2 A persistent autocrine cell (adapted from Tranquillo and
Lauffenburger, 1987). Curved arrows represent stimulation by
autocrine ligand at the leading edge of the migrating cell.
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Figure 4.3 The disrupted migration of an autocrine cell (adapted from
Tranquillo and Lauffenburger, 1987). Curved arrows represent
stimulation by autocrine ligand at the leading edge of the migrating
cell, straight arrows represent stimulation by exogenous ligand, and X's
represent the action of EGFR blocking antibodies.
o TGF complexes
* EGF complexes
'- v- -
oo0
O
OO
0 ..· U EE·
li 3 * **3
0 1
Ligand Concentration/lO 9
I
100
Figure 4.4 Model Results. Results were obtained from parameter
values reflecting a condition of low cell density and autocrine
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Appendix A
T-kGFR (LTGF
-k R. (exog + pAQt
- vf)  dt)
AvV 0
-k EGFLEGF + kTGFc TGF +kEGFCEGF
-keRRs + kecRi (1 - fdeg) - fQ
(eqn A.1)
S+k TGFR (L TGFf exog PAQjdf) f dt)
_kTGFCTGF keCTGF +
(eqn A.2)
= +k EGFR LEGFf s L-exog
dR,k
dt +keR- +kC+ TGF
-R1 (kdegfdeg + ke (I -
- EGF EGF - kEGF
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dC TGF
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Appendix B
Model Nomenclature Parameter Values
A = total area of cell culture dish (cm 2 ) 0.35
CTGF = surface complexes bound to TGF - a (# cell 1 )
CfEGF = surface complexes bound to EGF (# cell ')
f = autocrine capture probability for TGF - a 0.1
kec = internalization rate constant for complexes (min-') 0.3
keR = internalization rate constant for free receptors (min-') 0.03
kdeg = internal receptor degration rate constant (min- ') 2.2e-3
kf GF = forward binding rate constant for TGF - a (M -' min - ') 4.3e7
kEGF = forward binding rate constant for EGF (M-' min- ') 6.3e7
k,GF = reverse binding rate constant for TGF - a (min') 0.27
kEGF = reverse binding rate constant for EGF (min -') 0.16
krec = recycling rate constant (min-') 5.8e-2
LEGF = exogenous EGF concentration (M)
LGF = exogenous TGF -a concentration (M)
NA = Avagadro' s number (# mol -')
p = plated cell density (cells cm-2 ) 7143
Q = TGF - a autocrine secretion rate (# cell -' min - ') 8026
Ri = Total internal free receptors (# cell - ')
t = duration of experiment (min) 1440
V = volume of culture media above cells (L) 0.004
V,= free receptor synthesis rate (# cell -' min -') 100
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